Национальный медицинский исследовательский центр эндокринологии министерства здравоохранения российской федерации на правах рукописи кравцова наталия Сергеевна стимуляция сперматогенеза гонадотропинами и антиэстрогенами при патозооспермии и бесплодии
 Скачать 0.81 Mb.
|
|
Keskes R., Chakroun N., Sellami A., Belguith N., Kamoun H., Fakhfakh F., Ammar- Keskes L. Chromosomal defects in infertile men with poor semen quality. // J Assist Reprod Genet. -2012.- Vol. 29(5).-P451-456. 57. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL, Richards JS. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evi- dence for A kinase-independent signaling by FSH in granulosa cells. // Mol Endo- crinol. -2000.- Vol.14.-P.1283–1300. 58. Gregoriou, O., Bakas, P., Grigoriadis, C., Creatsa, M., Hassiakos, D., and Creatsas, G. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios. // Fertil Steril. -2012.-Vol.98.-P. 48–51. 59. Harrison S., Hull G., Pillai. Sperm acrosom status and sperm antibodies in infertility. // J Urol.-1998.-Vol.159.-P.1554-1558. 60. Hussein A., Ozgok Y., Ross L., Niederberger C. Clomiphene Administration for Cases of Nonobstructive Azoospermia: A Multicenter Study. // J Androl. – 2005. - Vol.26(6).-P.787-791. 61. Hussein A., Ozgok Y., Ross L., Rao P., Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. // Pol Med J.-2018.- XLV (267).- P.126-130. 62. Joshua D. Ring, Aye A. Lwin, and Tobias S Köhler . Current medical man- agement of endocrine-related male infertility. //Asian J Androl. -2016.- Vol.18(3).-P. 357–363. 86 63. Jungwirth A., Giwercman A., Tournaye H., Diemer T., Kopa Z., Dohle G., Krausz C. European Association of Urology guidelines on Male Infertility: the 2012 update. // Eur Urol. - 2012.- Vol.62(2).-P324-332. 64. Kadioglu T.C. Oral tamoxifen citrate treatment is more effective in normog- onadotropic patients who have follicle-stimulating hormone levels within the lower half of normal. // Int Urol Nephrol. - 2009.- Vol.41(4).-P.773-776. 65. Kato Y., Shiraishi K., Matsuyama H. Expression of testicular androgen re- ceptor in non-obstructive azoospermia and its change after hormonal therapy. // An- drology. -2014.-Vol.2(5).-P.734-740. 66. Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The treatment of hypogonadism in men of reproductive age. // Fertil Steril. -2013.-Vol.99.-P.718–724. 67. Kirk J.M., Savage M.O., Grant D.B., Bouloux P.M., Besser G.M. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism. // Clin Endocrinol.- 1994.-Vol.41(1).-P57-63. 68. Ko E.Y., Siddiqi K., Brannigan R.E., Sabanegh E.S. Empirical medical ther- apy for idiopathic male infertility: a survey of the American Urological Association. // J Urol.- 2012.-Vol.187.-P.973–978. 69. Krausz C., Giachini C. Genetic risk factors in male infertility.// Arch An- drol. -2007.- Vol.53(3).-P.125-133. 70. La Vignera S., Vicari E., Condorelli R.A., D'Agata R., Calogero A.E. Male accessory gland infection and sperm parameters (review). // Int J Androl. 2011.- Vol.34(5 Pt 2).-P.330-347. 71. Ley S.B., Leonard J.M. Male hypogonadotropic hypogonadism: factors influ- encing response to human chorionic gonadotropin and human menopausal gonadotro- pin, including prior exogenous androgens. // J Clin Endocrinol Metab. 2017.- Vol.61(4).-P746-752. 87 72. Liu P.Y., Gordon Baker H.W., Jayadev V., Zacharin M., Conway A.J., Han- delsman D.J. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin deficient infertile men: predictors of fertility outcome. // J Clin Endo- crinol Metab.- 2009.-Vol.94(3).-P.801. 73. Mascarenhas M.N., Flaxman S.R., Boerma T., Vanderpoel S., Stevens G.A. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. // PLoS Med.-2012.-Vol.9(12):e1001356. 74. Marcus K.A., Sweep C.G., van der Burgt I., Noordam C. Impaired Sertoli cell function in males diagnosed with Noonan syndrome. // J Pediatr Endocrinol Metab.- 2008.- Vol.21(11).-P.1079-1084. 75. Matsumoto A.M., Snyder P.J., Bhasin S., Martin K., Weber T., Winters S. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonad- otropic hypogonadism. // Fertil Steril.- 2009.- Vol.92(3).-P.979-990. 76. Monica Muratori, Elisabetta Baldi. Effects of FSH on Sperm DNA Fragmen- tation: Review of Clinical Studies and Possible Mechanisms of Action. // Front Endo- crinol (Lausanne). -2018.-Vol.9.-P.734. 77. Nieschlag E., Behre H.M., Nieschlag S., eds. Andrology – male reproductive health and dysfunction. Berlin: Springer, 2010. -629 p. 78. Nieschlag E., Bouloux P.G., Stegmann B.J., Shankar R.R., Guan Y., Tzontcheva A., McCrary Sisk C., Behre H.M. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hy- pogonadotropic hypogonadism. // Reprod Biol Endocrinol.- 2017.-Vol.15(1).-P.17. 79. Palomba S., Falbo A., Espinola S., Rocca M., Capasso S., Cappiello F., Zullo F. Effects of highly purified follicle-stimulating hormone on sperm DNA damage in men with male idiopathic subfertility: a pilot study. // J Endocrinol Invest. - 2011.- Vol.34(10).-P.747-752. 88 80. Paradisi R., Natali F., Fabbri R., Battaglia C., Seracchioli R., Venturoli S. Ev- idence for a stimulatory role of high doses of recombinant human follicle-stimulating hormone in the treatment of male-factor infertility. // Andrologia. 2014.-Vol.46(9).- P.1067-1072. 81. Parmegiani L., Cognigni G.E., Bernardi S., Troilo E., Ciampaglia W., Filicori M. “Physiologic ICSI”: hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. // Fertil Steril. -2010.-Vol.93.-P.598–604. 82. Patankar S.S., Kaore S.B., Sawane M.V., Mishra N.V., Deshkar A.M. Effect of clomiphene citrate on sperm density in male partners of infertile couples. // Indian J Physiol Pharmacol.- 2007.-Vol.- 51(2).P.195-198. 83. Patel D.P., Chandrapal J.C., Hotaling J.M. Hormone-Based Treatments in Subfertile Males.// Curr Urol Rep. -2016.- Vol.17(8).-P.56. 84. Punab M., Poolamets O., Paju P., Vihljajev V., Pomm K., Ladva R., Kor- rovits P., Laan M. Causes of male infertility: a 9-year prospective monocentre study on 1737 patients with reduced total sperm counts. // Hum Reprod. -2017.- Vol.32(1).-P.18- 31. 85. Ribeiro M.A., Gameiro L.F., Scarano W.R., Briton-Jones C., Kapoor A., Ro- sa M.B., El Dib R. Aromatase inhibitors in the treatment of oligozoospermic or azoo- spermic men: a systematic review of randomized controlled trials. // JBRA Assist Re- prod.-2016.- Vol.20(2).-P.82-88. 86. Rodriguez KM, Pastuszak AW, Lipshultz LI. Enclomiphene citrate for the treatment of secondary male hypogonadism Expert Opin Pharmacother.-2016.- Vol.17(11).-P.1561-1567. 87. Ross L.S., Kandel G.L., Prinz L.M., Auletta F. Clomiphene treatment of the idiopathic hypofertile male: high-dose, alternate-day therapy. // Fertil Steril. -2015.- Vol.33.-P.618–623. 89 88. Ruvolo G., Roccheri M.C., Brucculeri A.M., Longobardi S., Cittadini E., Bosco L. Lower sperm DNAfragmentation after r-FSH administration in function- al hypogonadotropic hypogonadism. // J Assist Reprod Genet.- 2013.- Vol.30(4).- P.497-503. 89. Sabanegh E.J., Agarwal A. Male infertility. Campbell-Walsh urology. 10th ed. - Philadelphia: Saunders Elsevier, 2012.- P. 616–647. 90. Saylam, B., Efesoy, O., and Cayan, S. The effect of aromatase inhibitor letro- zole on body mass index, serum hormones, and sperm parameters in infertile men. Fer- til Steril. -2011.- Vol.95.-P. 809–811. 91. Shiraishi K., Ohmi C., Shimabukuro T., Matsuyama H. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non- obstructive azoospermia. // Hum Reprod. -2012.-Vol.27(2).-P.331-339. 92. Shiraishi K., Matsuyama H. Gonadotoropin actions on spermatogenesis and hormonal therapies for spermatogenic disorders [Review]. //Endocr J.- 2017.- Vol.64(2).-P.123-131. 93. Schlegel P.N. Aromatase inhibitors for male infertility. // Fertil Steril. -2012.- Vol.98.-P.1359–1362. 94. Stephens S.M., Polotsky A.J. Big enough for an aromatase inhibitor? How adiposity affects male fertility. // Semin Reprod Med. -2013.-Vol.31.P.251–257. 95. Simoni М. et al. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor poly- morphism p.N680S: a pharmacogenetic study. // Hum Reprod.- 2016.- Vol.31(9).-P. 1960-1969. 96. Sinisi A.A. , Esposito D., Bellastella G., Maione L., Palumbo V., Gandini L., Lombardo F., De Bellis A., Lenzi A., Bellastella A. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism. // J Endocrinol Invest.- 2010.- Vol.33(9).-P.618-623. 90 97. Strehler E., Sterzik K., De Santo M., Abt M., Wiedemann R., Bellati U., Col- lodel G., Piomboni P., Baccetti B. The effect of follicle-stimulating hormone therapy on sperm quality: an ultrastructural mathematical evaluation. // J Androl. –1997.- Vol.18(4).-P.439-447. 98. Valenti D., La Vignera S., Condorelli R.A., Rago R., Barone N., Vicari E., Calogero A.E. Follicle-stimulating hormone treatment in normogonadotropic infer- tile men. // Nat Rev Urol. - 2013.- Vol.10(1).-P.55-62. 99. Veličko I., Ploner A., Sparén P., Marions L., Herrmann B., Kühlmann- Berenzon S. Sexual and testing behaviour associated with Chlamydia trachomatis in- fection: a cohort study in an STI clinic in Sweden. // BMJ Open.- 2016.- Vol. 6(8).- e011312. 100. Verón GL, Molina RI, Tissera AD, Estofan GM, Marín-Briggiler CI, Vazquez-Levin MH1. Incidence of Sperm Surface Autoantibodies and Relationship with Routine Semen Parameters and Sperm Kinematics. // Am J Reprod Immunol.- 2016.-Vol.76(1).-P.59-69. 101. Warne D.W., Decosterd G., Okada H., Yano Y., Koide N., Howles C.M. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle- stimulating hormone and human chorionic gonadotropin. // Fertil Steril.- 2008. - Vol.16.-P.132-136. 102. Willets A.E., Corbo J.M., Brown J.N. Clomiphene for the treatment of male infertility. // Reprod Sci.- 2013.-Vol.20(7).-P.739-744. 103. Yagci A., Murk W., Stronk J., Huszar G. Spermatozoa bound to solid state hyaluronic acid show chromatin structure with high DNA chain integrity: an acri- dine orange fluorescence study. J Androl.(2010) 31:566–72. 104. Zacharin M. , Sabin M.A., Nair V.V., Dabadghao P. Addition of recom- binant follicle-stimulating hormone to human chorionic gonadotropin treatment in ado- lescents and young adults with hypogonadotropic hypogonadism promotes normal tes- 91 ticular growth and may promote early spermatogenesis. // Fertil Steril.- 2012.- Vol.98(4).-P.836-842. 105. Zini A., Fahmy N., Belzile E., Ciampi A., Al-Hathal N., Kotb A. Anti- sperm antibodies are not associated with pregnancy rates after IVF and ICSI: systemat- ic review and meta-analysis. // Hum Reprod.- 2011.-Vol. 26(6).-P.1288-1295. |